Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
About This Webinar
Patient-focused drug development (PFDD) is a systematic approach to help ensure that patients' experiences, perspectives, needs, and priorities are captured and meaningfully incorporated into drug development and evaluation.
Rare Disease Drug Development due to the challenges involved adds another layer of complexity to Patient-Focused drug development. This insightful webinar will include patient, and industry perspectives, led by Zizi Imatorbhebhe.
Agenda
- Why Patient-Focused Drug development is used and recommended by regulatory agencies such as the FDA
- The benefits of including patient insight at the various stages of drug development
- The barriers faced by the industry in bringing greater patient involvement into clinical trial design and how to remedy them?
- How to assure patients will feel valued as collaborators in trial development.
- Q&A with our experts
Language:
English
Who can attend? Anyone with the event link can attend
Featured Presenters
Founder & Managing Director
Senior Vice President, Global Strategy & Development, Rare Disease
Zizi is a seasoned executive with over 32+ years of drug development and commercial experience in the Bio-pharmaceutical, Clinical Research (CRO) and Healthcare industry. She has been instrumental in working collaboratively with many global sponsors especially in the Rare Disease space to identify drug development challenges for their programs and providing solutions to address them. She has also successfully commercialized over 25 pharmaceutical and medical device products globally. In addition, she works to leverage innovations to develop patient-oriented solutions and expand clinical trial access.
Patient Advocate
Ella Balasa is a patient advocate, consultant, and person living with cystic fibrosis. She has committed her time to empower patients and advancing healthcare strategies. She speaks publicly about the value of patient perspective and is passionate about distilling clinical information for patient communities. Through opportunities working with healthcare organizations on content strategy, writing, speaking, clinical trial development, and sharing the patient experience, she aims to affect the healthcare landscape by raising awareness of rare diseases, promoting self-advocacy to patients, and valuable insights to organizations.
Founded in 1997, Ergomed is a global provider of high-quality services to the biopharmaceutical industry, spanning all phases of clinical trials, post-approval pharmacovigilance, and medical information. Ergomed Clinical Research is a complete, global Phase I-IV clinical development and trial management service with a strong heritage in the development of drugs in rare diseases and oncology.
Contact: https://ergomedplc.com/contact-us/
Contact: https://ergomedplc.com/contact-us/
Hosted By
BioAlliance Video Network's Webinars and Video Conferences